Zealthy

Zealthy is a virtual healthcare platform founded in 2023 and based in New York City. The company specializes in GLP-1 weight loss programs, connecting patients with board-certified physicians who can prescribe compounded semaglutide and tirzepatide, as well as FDA-approved branded medications like Wegovy and Zepbound. Beyond weight loss, Zealthy also offers telehealth services for anxiety, depression, primary care, birth control, erectile dysfunction, and hair loss — making it one of the more comprehensive direct-to-consumer telehealth platforms in the market. Zealthy's weight loss program is built around a physician-supervised model. Every patient begins with a detailed health intake and a video consultation with a licensed clinician who evaluates their candidacy for GLP-1 therapy. Clinicians review BMI, weight history, comorbidities, and current medications before prescribing. Once prescribed, compounded semaglutide and tirzepatide are shipped to the patient's door within one to four business days, with doses calibrated to the standard titration protocols used in clinical trials. One of Zealthy's standout features is its insurance coordination service. Unlike many compounded GLP-1 platforms that exclusively serve cash-pay patients, Zealthy employs a dedicated team that submits prior authorization requests for FDA-approved GLP-1 medications on patients' behalf. This can reduce the cost of branded medications like Wegovy from over $1,300 per month to as little as $25 per month for patients with qualifying insurance plans. Zealthy operates in approximately 34 states. The platform offers same-day and next-day appointments, asynchronous messaging with providers between visits, and a mobile app for tracking progress and communicating with the care team. Monthly follow-up visits are built into the membership to ensure appropriate dose titration and clinical monitoring throughout treatment. The platform has positioned itself as a value-focused alternative to premium GLP-1 services, offering lower membership fees than many competitors while maintaining physician oversight. Patients who want a streamlined, app-driven experience with access to both compounded and branded GLP-1 options — along with active insurance support — will find Zealthy a competitive option in the crowded weight loss telehealth market. Beyond weight loss, Zealthy also offers telehealth services for anxiety, depression, primary care, birth control, erectile dysfunction, and hair loss — making it one of the more comprehensive direct-to-consumer telehealth platforms in the market. Zealthy's weight loss program is built around a physician-supervised model. Every patient begins with a detailed health intake and a video consultation with a licensed clinician who evaluates their candidacy for GLP-1 therapy. Clinicians review BMI, weight history, comorbidities, and current medications before prescribing. Once prescribed, compounded semaglutide and tirzepatide are shipped to the patient's door within one to four business days, with doses calibrated to the standard titration protocols used in clinical trials. One of Zealthy's standout features is its insurance coordination service. Unlike many compounded GLP-1 platforms that exclusively serve cash-pay patients, Zealthy employs a dedicated team that submits prior authorization requests for FDA-approved GLP-1 medications on patients' behalf. This can reduce the cost of branded medications like Wegovy from over $1,300 per month to as little as $25 per month for patients with qualifying insurance plans. Zealthy operates in approximately 34 states. The platform offers same-day and next-day appointments, asynchronous messaging with providers between visits, and a mobile app for tracking progress and communicating with the care team. Monthly follow-up visits are built into the membership to ensure appropriate dose titration and clinical monitoring throughout treatment. The platform has positioned itself as a value-focused alternative to premium GLP-1 services, offering lower membership fees than many competitors while maintaining physician oversight. Patients who want a streamlined, app-driven experience with access to both compounded and branded GLP-1 options — along with active insurance support — will find Zealthy a competitive option in the crowded weight loss telehealth market.